Skip to main content
. 2021 Jul 11;39(6):1604–1612. doi: 10.1007/s10637-021-01145-y

Fig. 1.

Fig. 1

Seribantumab pharmacokinetic parameters by dose. a Area under the curve up to last measurable concentration (weeks mg/L). b Maximum serum concentration (mg/L). c Minimum serum concentration (mg/L). d Half-life (weeks). e Time to maximum concentration (weeks). f Volume of distribution (L)